APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pneumonia Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pneumonia Vaccine Industry Growth and Trends Forecast to 2032

Report ID 174026830122 December 2025100 pages

Choose your research edition.

Industry ResearchPneumonia Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pneumonia Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pneumonia Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pneumonia Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Pneumonia Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pneumonia Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pneumonia Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pneumonia Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pneumonia Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pneumonia Vaccine include Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Glaxosmithkline Plc., Zhifei Biologic, Walvax Biotechnology, Serum Institute of India Pvt. Ltd., Sanofi Pasteur and Royal (Wuxi) Bio-Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pneumonia Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pneumonia Vaccine market size, estimates, and forecasts are presented in terms of sales volume (doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pneumonia Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pneumonia Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pneumonia Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pneumonia Vaccine Market by Company

Johnson & Johnson

Merck & Co., Inc.

Pfizer Inc.

Glaxosmithkline Plc.

Zhifei Biologic

Walvax Biotechnology

Serum Institute of India Pvt. Ltd.

Sanofi Pasteur

Royal (Wuxi) Bio-Pharmaceutical

Emergent Biosolutions

CSL Limited

Astrazeneca Plc.

Astellas Pharma Inc.

Pneumonia Vaccine Segment by Type

Pneumococcal Conjugate Vaccine (PCV13)

Pneumococcal Polysaccharide Vaccine (PPSV23)

Other

Pneumonia Vaccine Segment by Application

Sepsis

Meningitis

Pneumonia

Pneumonia Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumonia Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pneumonia Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumonia Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pneumonia Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pneumonia Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Pneumococcal Conjugate Vaccine (PCV13) Table 2. Major Company of Pneumococcal Polysaccharide Vaccine (PPSV23) Table 3. Major Company of Other Table 4. Global Pneumonia Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 6. Global Pneumonia Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pneumonia Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pneumonia Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Pneumonia Vaccine Price by Type (2021-2026) & (US$/dose) Table 10. Global Pneumonia Vaccine Sales by Type (2027-2032) & (doses) Table 11. Global Pneumonia Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pneumonia Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pneumonia Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Pneumonia Vaccine Price by Type (2027-2032) & (US$/dose) Table 15. North America Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 16. North America Pneumonia Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 18. Europe Pneumonia Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 20. Asia-Pacific Pneumonia Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 22. Latin America Pneumonia Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pneumonia Vaccine Sales by Type (2021-2026) & (doses) Table 24. Middle East and Africa Pneumonia Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Pneumonia Vaccine Industry Trends Table 26. Pneumonia Vaccine Industry Drivers Table 27. Pneumonia Vaccine Industry Opportunities and Challenges Table 28. Pneumonia Vaccine Industry Restraints Table 29. Global Pneumonia Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pneumonia Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Pneumonia Vaccine Sales by Company (2021-2026) & (doses) Table 32. Global Pneumonia Vaccine Sales Share by Company (2021-2026) Table 33. Global Pneumonia Vaccine Market Price by Company (2021-2026) & (US$/dose) Table 34. Global Pneumonia Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pneumonia Vaccine Major Company Production Sites and Headquarters Table 36. Global Pneumonia Vaccine Company, Product Type & Application Table 37. Global Pneumonia Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pneumonia Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pneumonia Vaccine Sales by Region (2021-2026) & (doses) Table 42. Global Pneumonia Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pneumonia Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pneumonia Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Pneumonia Vaccine Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 46. Global Pneumonia Vaccine Sales by Region (2027-2032) & (doses) Table 47. Global Pneumonia Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pneumonia Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pneumonia Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Pneumonia Vaccine Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2027-2032) Table 51. Global Pneumonia Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 53. Global Pneumonia Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pneumonia Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pneumonia Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Pneumonia Vaccine Price by Application (2021-2026) & (US$/dose) Table 57. Global Pneumonia Vaccine Sales by Application (2027-2032) & (doses) Table 58. Global Pneumonia Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pneumonia Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pneumonia Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Pneumonia Vaccine Price by Application (2027-2032) & (US$/dose) Table 62. North America Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 63. North America Pneumonia Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 65. Europe Pneumonia Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 67. Asia-Pacific Pneumonia Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 69. Latin America Pneumonia Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pneumonia Vaccine Sales by Application (2021-2026) & (doses) Table 71. Middle East and Africa Pneumonia Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Johnson & Johnson Company Information Table 73. Johnson & Johnson Business Overview Table 74. Johnson & Johnson Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Pneumonia Vaccine Product Portfolio Table 76. Johnson & Johnson Recent Development Table 77. Merck & Co., Inc. Company Information Table 78. Merck & Co., Inc. Business Overview Table 79. Merck & Co., Inc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 80. Merck & Co., Inc. Pneumonia Vaccine Product Portfolio Table 81. Merck & Co., Inc. Recent Development Table 82. Pfizer Inc. Company Information Table 83. Pfizer Inc. Business Overview Table 84. Pfizer Inc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 85. Pfizer Inc. Pneumonia Vaccine Product Portfolio Table 86. Pfizer Inc. Recent Development Table 87. Glaxosmithkline Plc. Company Information Table 88. Glaxosmithkline Plc. Business Overview Table 89. Glaxosmithkline Plc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 90. Glaxosmithkline Plc. Pneumonia Vaccine Product Portfolio Table 91. Glaxosmithkline Plc. Recent Development Table 92. Zhifei Biologic Company Information Table 93. Zhifei Biologic Business Overview Table 94. Zhifei Biologic Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 95. Zhifei Biologic Pneumonia Vaccine Product Portfolio Table 96. Zhifei Biologic Recent Development Table 97. Walvax Biotechnology Company Information Table 98. Walvax Biotechnology Business Overview Table 99. Walvax Biotechnology Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 100. Walvax Biotechnology Pneumonia Vaccine Product Portfolio Table 101. Walvax Biotechnology Recent Development Table 102. Serum Institute of India Pvt. Ltd. Company Information Table 103. Serum Institute of India Pvt. Ltd. Business Overview Table 104. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 105. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Portfolio Table 106. Serum Institute of India Pvt. Ltd. Recent Development Table 107. Sanofi Pasteur Company Information Table 108. Sanofi Pasteur Business Overview Table 109. Sanofi Pasteur Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 110. Sanofi Pasteur Pneumonia Vaccine Product Portfolio Table 111. Sanofi Pasteur Recent Development Table 112. Royal (Wuxi) Bio-Pharmaceutical Company Information Table 113. Royal (Wuxi) Bio-Pharmaceutical Business Overview Table 114. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 115. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Portfolio Table 116. Royal (Wuxi) Bio-Pharmaceutical Recent Development Table 117. Emergent Biosolutions Company Information Table 118. Emergent Biosolutions Business Overview Table 119. Emergent Biosolutions Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 120. Emergent Biosolutions Pneumonia Vaccine Product Portfolio Table 121. Emergent Biosolutions Recent Development Table 122. CSL Limited Company Information Table 123. CSL Limited Business Overview Table 124. CSL Limited Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 125. CSL Limited Pneumonia Vaccine Product Portfolio Table 126. CSL Limited Recent Development Table 127. Astrazeneca Plc. Company Information Table 128. Astrazeneca Plc. Business Overview Table 129. Astrazeneca Plc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 130. Astrazeneca Plc. Pneumonia Vaccine Product Portfolio Table 131. Astrazeneca Plc. Recent Development Table 132. Astellas Pharma Inc. Company Information Table 133. Astellas Pharma Inc. Business Overview Table 134. Astellas Pharma Inc. Pneumonia Vaccine Sales (doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 135. Astellas Pharma Inc. Pneumonia Vaccine Product Portfolio Table 136. Astellas Pharma Inc. Recent Development Table 137. North America Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 138. North America Pneumonia Vaccine Sales by Country (2021-2026) & (doses) Table 139. North America Pneumonia Vaccine Sales Market Share by Country (2021-2026) Table 140. North America Pneumonia Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 141. North America Pneumonia Vaccine Sales Market Share Forecast by Country (2027-2032) Table 142. North America Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Pneumonia Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Pneumonia Vaccine Market Share by Country (2021-2026) Table 145. North America Pneumonia Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Pneumonia Vaccine Market Share Forecast by Country (2027-2032) Table 147. Europe Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 148. Europe Pneumonia Vaccine Sales by Country (2021-2026) & (doses) Table 149. Europe Pneumonia Vaccine Sales Market Share by Country (2021-2026) Table 150. Europe Pneumonia Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 151. Europe Pneumonia Vaccine Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Pneumonia Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Pneumonia Vaccine Market Share by Country (2021-2026) Table 155. Europe Pneumonia Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Pneumonia Vaccine Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Pneumonia Vaccine Sales by Country (2021-2026) & (doses) Table 159. Asia-Pacific Pneumonia Vaccine Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Pneumonia Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 161. Asia-Pacific Pneumonia Vaccine Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Pneumonia Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Pneumonia Vaccine Market Share by Country (2021-2026) Table 165. Asia-Pacific Pneumonia Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Pneumonia Vaccine Market Share Forecast by Country (2027-2032) Table 167. Latin America Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 168. Latin America Pneumonia Vaccine Sales by Country (2021-2026) & (doses) Table 169. Latin America Pneumonia Vaccine Sales Market Share by Country (2021-2026) Table 170. Latin America Pneumonia Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 171. Latin America Pneumonia Vaccine Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Pneumonia Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Pneumonia Vaccine Market Share by Country (2021-2026) Table 175. Latin America Pneumonia Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Pneumonia Vaccine Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (doses): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Pneumonia Vaccine Sales by Country (2021-2026) & (doses) Table 179. Middle East and Africa Pneumonia Vaccine Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Pneumonia Vaccine Sales Forecast by Country (2027-2032) & (doses) Table 181. Middle East and Africa Pneumonia Vaccine Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Pneumonia Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Pneumonia Vaccine Market Share by Country (2021-2026) Table 185. Middle East and Africa Pneumonia Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Pneumonia Vaccine Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Pneumonia Vaccine Distributors List Table 190. Pneumonia Vaccine Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Pneumonia Vaccine Image Figure 2. Global Pneumonia Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pneumonia Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Pneumonia Vaccine Sales (2021-2032) & (doses) Figure 5. Pneumococcal Conjugate Vaccine (PCV13) Image Figure 6. Global Pneumococcal Conjugate Vaccine (PCV13) Sales YoY Growth (2021-2032) & (doses) Figure 7. Pneumococcal Polysaccharide Vaccine (PPSV23) Image Figure 8. Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales YoY Growth (2021-2032) & (doses) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (doses) Figure 11. Global Pneumonia Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pneumonia Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Pneumonia Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Pneumonia Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Pneumonia Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pneumonia Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pneumonia Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pneumonia Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pneumonia Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pneumonia Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pneumonia Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pneumonia Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pneumonia Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Sepsis Image Figure 26. Global Sepsis Sales YoY Growth (2021-2032) & (doses) Figure 27. Meningitis Image Figure 28. Global Meningitis Sales YoY Growth (2021-2032) & (doses) Figure 29. Pneumonia Image Figure 30. Global Pneumonia Sales YoY Growth (2021-2032) & (doses) Figure 31. Global Pneumonia Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pneumonia Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Pneumonia Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Pneumonia Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Pneumonia Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pneumonia Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pneumonia Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pneumonia Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pneumonia Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pneumonia Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pneumonia Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pneumonia Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Pneumonia Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 44. North America Pneumonia Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pneumonia Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pneumonia Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pneumonia Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 48. Europe Pneumonia Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pneumonia Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pneumonia Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pneumonia Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 52. Asia-Pacific Pneumonia Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pneumonia Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pneumonia Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pneumonia Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 56. Latin America Pneumonia Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pneumonia Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pneumonia Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pneumonia Vaccine Sales by Country: 2021 VS 2025 VS 2032 (doses) Figure 60. Middle East and Africa Pneumonia Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pneumonia Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pneumonia Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pneumonia Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pneumonia Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Pneumococcal Conjugate Vaccine (PCV13)
  • Pneumococcal Polysaccharide Vaccine (PPSV23)
  • Other
Applications
  • Sepsis
  • Meningitis
  • Pneumonia
Companies covered
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Glaxosmithkline Plc.
  • Zhifei Biologic
  • Walvax Biotechnology
  • Serum Institute of India Pvt. Ltd.
  • Sanofi Pasteur
  • Royal (Wuxi) Bio-Pharmaceutical
  • Emergent Biosolutions
  • CSL Limited
  • Astrazeneca Plc.
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pneumonia Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pneumonia Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pneumonia Vaccine Market by Type
  6. 1.3.1 Pneumococcal Conjugate Vaccine (PCV13)
  7. 1.3.2 Pneumococcal Polysaccharide Vaccine (PPSV23)
  8. 1.3.3 Other
  9. 1.4 Global Pneumonia Vaccine Market Size by Type
  10. 1.4.1 Global Pneumonia Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pneumonia Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pneumonia Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pneumonia Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pneumonia Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pneumonia Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pneumonia Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pneumonia Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pneumonia Vaccine Industry Trends
  2. 2.2 Pneumonia Vaccine Industry Drivers
  3. 2.3 Pneumonia Vaccine Industry Opportunities and Challenges
  4. 2.4 Pneumonia Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pneumonia Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Pneumonia Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Pneumonia Vaccine Price (2021-2026)
  4. 3.4 Global Pneumonia Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pneumonia Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Pneumonia Vaccine Company, Product Type & Application
  7. 3.7 Global Pneumonia Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pneumonia Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pneumonia Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pneumonia Vaccine Tier 1, Tier 2, and Tier 3
4 Pneumonia Vaccine Regional Status and Outlook
  1. 4.1 Global Pneumonia Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pneumonia Vaccine Historic Market Size by Region
  3. 4.2.1 Global Pneumonia Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pneumonia Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pneumonia Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pneumonia Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Pneumonia Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pneumonia Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pneumonia Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pneumonia Vaccine by Application
  1. 5.1 Pneumonia Vaccine Market by Application
  2. 5.1.1 Sepsis
  3. 5.1.2 Meningitis
  4. 5.1.3 Pneumonia
  5. 5.2 Global Pneumonia Vaccine Market Size by Application
  6. 5.2.1 Global Pneumonia Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pneumonia Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pneumonia Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pneumonia Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pneumonia Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pneumonia Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pneumonia Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pneumonia Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Pneumonia Vaccine Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Pneumonia Vaccine Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 Pfizer Inc.
  14. 6.3.1 Pfizer Inc. Company Information
  15. 6.3.2 Pfizer Inc. Business Overview
  16. 6.3.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Inc. Pneumonia Vaccine Product Portfolio
  18. 6.3.5 Pfizer Inc. Recent Developments
  19. 6.4 Glaxosmithkline Plc.
  20. 6.4.1 Glaxosmithkline Plc. Company Information
  21. 6.4.2 Glaxosmithkline Plc. Business Overview
  22. 6.4.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Glaxosmithkline Plc. Pneumonia Vaccine Product Portfolio
  24. 6.4.5 Glaxosmithkline Plc. Recent Developments
  25. 6.5 Zhifei Biologic
  26. 6.5.1 Zhifei Biologic Company Information
  27. 6.5.2 Zhifei Biologic Business Overview
  28. 6.5.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zhifei Biologic Pneumonia Vaccine Product Portfolio
  30. 6.5.5 Zhifei Biologic Recent Developments
  31. 6.6 Walvax Biotechnology
  32. 6.6.1 Walvax Biotechnology Company Information
  33. 6.6.2 Walvax Biotechnology Business Overview
  34. 6.6.3 Walvax Biotechnology Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Walvax Biotechnology Pneumonia Vaccine Product Portfolio
  36. 6.6.5 Walvax Biotechnology Recent Developments
  37. 6.7 Serum Institute of India Pvt. Ltd.
  38. 6.7.1 Serum Institute of India Pvt. Ltd. Company Information
  39. 6.7.2 Serum Institute of India Pvt. Ltd. Business Overview
  40. 6.7.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Portfolio
  42. 6.7.5 Serum Institute of India Pvt. Ltd. Recent Developments
  43. 6.8 Sanofi Pasteur
  44. 6.8.1 Sanofi Pasteur Company Information
  45. 6.8.2 Sanofi Pasteur Business Overview
  46. 6.8.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sanofi Pasteur Pneumonia Vaccine Product Portfolio
  48. 6.8.5 Sanofi Pasteur Recent Developments
  49. 6.9 Royal (Wuxi) Bio-Pharmaceutical
  50. 6.9.1 Royal (Wuxi) Bio-Pharmaceutical Company Information
  51. 6.9.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
  52. 6.9.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Portfolio
  54. 6.9.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
  55. 6.10 Emergent Biosolutions
  56. 6.10.1 Emergent Biosolutions Company Information
  57. 6.10.2 Emergent Biosolutions Business Overview
  58. 6.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Emergent Biosolutions Pneumonia Vaccine Product Portfolio
  60. 6.10.5 Emergent Biosolutions Recent Developments
  61. 6.11 CSL Limited
  62. 6.11.1 CSL Limited Company Information
  63. 6.11.2 CSL Limited Business Overview
  64. 6.11.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CSL Limited Pneumonia Vaccine Product Portfolio
  66. 6.11.5 CSL Limited Recent Developments
  67. 6.12 Astrazeneca Plc.
  68. 6.12.1 Astrazeneca Plc. Company Information
  69. 6.12.2 Astrazeneca Plc. Business Overview
  70. 6.12.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Astrazeneca Plc. Pneumonia Vaccine Product Portfolio
  72. 6.12.5 Astrazeneca Plc. Recent Developments
  73. 6.13 Astellas Pharma Inc.
  74. 6.13.1 Astellas Pharma Inc. Company Information
  75. 6.13.2 Astellas Pharma Inc. Business Overview
  76. 6.13.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Astellas Pharma Inc. Pneumonia Vaccine Product Portfolio
  78. 6.13.5 Astellas Pharma Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Pneumonia Vaccine Sales by Country
  2. 7.1.1 North America Pneumonia Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pneumonia Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Pneumonia Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pneumonia Vaccine Market Size by Country
  6. 7.2.1 North America Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pneumonia Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Pneumonia Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pneumonia Vaccine Sales by Country
  2. 8.1.1 Europe Pneumonia Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pneumonia Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Pneumonia Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pneumonia Vaccine Market Size by Country
  6. 8.2.1 Europe Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pneumonia Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pneumonia Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pneumonia Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Pneumonia Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pneumonia Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pneumonia Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pneumonia Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pneumonia Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pneumonia Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pneumonia Vaccine Sales by Country
  2. 10.1.1 South America Pneumonia Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pneumonia Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Pneumonia Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pneumonia Vaccine Market Size by Country
  6. 10.2.1 South America Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pneumonia Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Pneumonia Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pneumonia Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Pneumonia Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pneumonia Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pneumonia Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pneumonia Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Pneumonia Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pneumonia Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pneumonia Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pneumonia Vaccine Value Chain Analysis
  2. 12.1.1 Pneumonia Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pneumonia Vaccine Production Mode & Process
  7. 12.2 Pneumonia Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pneumonia Vaccine Distributors
  10. 12.2.3 Pneumonia Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst